Table I.
Group | Time, mins | MAP, mmHg | HR, bpm | pH | PaCO2, mmHg | LAC, mmol/l | BE, mmol/l | HCO3-, mmol/l |
---|---|---|---|---|---|---|---|---|
CPR | Baseline | 95.6±19.6 | 367±59 | 7.34±0.49 | 35±8 | 1.1±0.5 | −6.9±2.7 | 18.9±2.0 |
30 | 72.9±14.7 | 351±46 | 7.29±0.07 | 41±12 | 3.1±0.7 | −10.4±2.4 | 16.0±2.3 | |
60 | 73.2±16.5 | 365±31 | 7.28±0.06 | 46±7 | 2.5±0.3 | −6.0±2.5 | 19.1±2.2 | |
120 | 72.3±17.2 | 351±48 | 7.32±0.07 | 42±13 | 2.4±0.6 | −5.8± 2.7 | 18.8±3.5 | |
EIso | Baseline | 97.9±17.8 | 362±72 | 7.33±0.03 | 34±3 | 1.7±0.6 | −7.5±2.6 | 18.6±1.7 |
30 | 71.3±14.4 | 359±43 | 7.24±0.08 | 35±10 | 3.7±1.4 | −11.5±3.6 | 15.3±2.3 | |
60 | 75.4±16.9 | 364±49 | 7.23±0.09 | 47±13 | 2.5±1.0 | −7.6±2.5 | 17.6±2.0 | |
120 | 73.8±13.8 | 351±39 | 7.32±0.12 | 46±11 | 2.3±0.4 | −5.6±3.4 | 17.8±3.1 | |
EIso+TH | Baseline | 101.6±14.2 | 341±56 | 7.35±0.04 | 34±6 | 1.0±0.3 | −6.1±2.2 | 19.6±1.9 |
30 | 72.6±13.6 | 323±30 | 7.33±0.09 | 43±17 | 3.2±1.5 | −9.7±2.3 | 16.0±1.7 | |
60 | 78.3±14.3 | 366±42 | 7.25±0.06 | 47±8 | 2.6±0.4 | −6.1±2.7 | 18.4±1.9 | |
120 | 74.2±12.7 | 361±32 | 7.28±0.11 | 44±12 | 2.3±0.4 | −5.7±2.5 | 18.0±2.7 | |
TH | Baseline | 104.9±15.6 | 371±58 | 7.31±0.08 | 32±4 | 1.2±0.3 | −6.2±3.8 | 19.1±3.0 |
30 | 74.5±13.9 | 342±35 | 7.27±0.09 | 36±12 | 4.1±1.5 | −12.5±3.5 | 15.2±2.4 | |
60 | 75.6±11.2 | 359±33 | 7.28±0.06 | 48±16 | 2.5±0.2 | −7.5±2.1 | 17.7±1.8 | |
120 | 75.2±13.5 | 341±43 | 7.26±0.10 | 45±12 | 2.3±0.6 | −5.5±3.6 | 17.3±4.5 |
All values are reported as mean ± standard deviation. No differences were observed between the groups. CPR, cardiopulmonary resuscitation; EIso, emulsified isoflurane; TH, therapeutic hypothermia; MAP, mean arterial pressure; HR, heart rate; PaCO2, partial pressure of CO2; LAC, lupus anti-coagulant; BE, base excess; bpm, beats per minute.